Annual Accounts Payable
$1.46 M
-$1.35 M-48.10%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual accounts payable is $1.46 million, with the most recent change of -$1.35 million (-48.10%) on December 31, 2023.
- During the last 3 years, CTMX annual accounts payable has fallen by -$1.54 million (-51.34%).
- CTMX annual accounts payable is now -77.90% below its all-time high of $6.60 million, reached on December 31, 2016.
Performance
CTMX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.42 M
+$811.00 K+132.73%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly accounts payable is $1.42 million, with the most recent change of +$811.00 thousand (+132.73%) on September 30, 2024.
- Over the past year, CTMX quarterly accounts payable has dropped by -$283.00 thousand (-16.60%).
- CTMX quarterly accounts payable is now -85.05% below its all-time high of $9.51 million, reached on March 31, 2019.
Performance
CTMX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CTMX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.1% | -16.6% |
| 3 y3 years | -51.3% | -16.6% |
| 5 y5 years | -71.6% | -16.6% |
CTMX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -48.3% | at low | -72.5% | +132.7% |
| 5 y | 5-year | -64.9% | at low | -72.5% | +132.7% |
| alltime | all time | -77.9% | +56.8% | -85.0% | +175.1% |
CytomX Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.42 M(+132.7%) |
| Jun 2024 | - | $611.00 K(-68.9%) |
| Mar 2024 | - | $1.96 M(+34.7%) |
| Dec 2023 | $1.46 M(-48.1%) | $1.46 M(-14.5%) |
| Sep 2023 | - | $1.71 M(+65.7%) |
| Jun 2023 | - | $1.03 M(-53.3%) |
| Mar 2023 | - | $2.20 M(-21.6%) |
| Dec 2022 | $2.81 M(-0.3%) | $2.81 M(-45.7%) |
| Sep 2022 | - | $5.18 M(+169.6%) |
| Jun 2022 | - | $1.92 M(+11.6%) |
| Mar 2022 | - | $1.72 M(-38.9%) |
| Dec 2021 | $2.82 M(-5.9%) | $2.82 M(+85.9%) |
| Sep 2021 | - | $1.52 M(-13.6%) |
| Jun 2021 | - | $1.75 M(-32.0%) |
| Mar 2021 | - | $2.58 M(-13.8%) |
| Dec 2020 | $3.00 M(-27.9%) | $3.00 M(-17.8%) |
| Sep 2020 | - | $3.64 M(-26.1%) |
| Jun 2020 | - | $4.93 M(+30.3%) |
| Mar 2020 | - | $3.78 M(-9.0%) |
| Dec 2019 | $4.16 M | $4.16 M(-8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $4.55 M(+0.7%) |
| Jun 2019 | - | $4.52 M(-52.5%) |
| Mar 2019 | - | $9.51 M(+85.3%) |
| Dec 2018 | $5.13 M(+22.0%) | $5.13 M(-25.3%) |
| Sep 2018 | - | $6.87 M(+62.1%) |
| Jun 2018 | - | $4.24 M(-20.7%) |
| Mar 2018 | - | $5.35 M(+27.2%) |
| Dec 2017 | $4.21 M(-36.2%) | $4.21 M(+46.6%) |
| Sep 2017 | - | $2.87 M(-54.9%) |
| Jun 2017 | - | $6.36 M(+72.0%) |
| Mar 2017 | - | $3.70 M(-43.9%) |
| Dec 2016 | $6.60 M(+40.4%) | $6.60 M(+1175.8%) |
| Sep 2016 | - | $517.00 K(-63.7%) |
| Jun 2016 | - | $1.43 M(-71.2%) |
| Mar 2016 | - | $4.96 M(+5.6%) |
| Dec 2015 | $4.70 M(+144.8%) | $4.70 M(+74.0%) |
| Sep 2015 | - | $2.70 M(+255.3%) |
| Jun 2015 | - | $760.00 K(-60.4%) |
| Dec 2014 | $1.92 M(+106.3%) | $1.92 M |
| Dec 2013 | $930.00 K | - |
FAQ
- What is CytomX Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for CytomX Therapeutics?
- What is CytomX Therapeutics annual accounts payable year-on-year change?
- What is CytomX Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly accounts payable year-on-year change?
What is CytomX Therapeutics annual accounts payable?
The current annual accounts payable of CTMX is $1.46 M
What is the all time high annual accounts payable for CytomX Therapeutics?
CytomX Therapeutics all-time high annual accounts payable is $6.60 M
What is CytomX Therapeutics annual accounts payable year-on-year change?
Over the past year, CTMX annual accounts payable has changed by -$1.35 M (-48.10%)
What is CytomX Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CTMX is $1.42 M
What is the all time high quarterly accounts payable for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly accounts payable is $9.51 M
What is CytomX Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CTMX quarterly accounts payable has changed by -$283.00 K (-16.60%)